
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
BBOT is a biotechnology company developing targeted therapies for cancers driven by RAS signaling and PI3Kα. The company focuses on rational drug design to inhibit the active ON state of RAS and to selectively block RAS-driven PI3K activation, aiming at multiple KRAS mutants and novel approaches to maximize target inhibition. BBOT translates decades of RAS biology research into therapeutic candidates intended to improve outcomes for patients with RAS- and PI3Kα-driven tumors.
🕒 March 27
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
BBOT is a biotechnology company developing targeted therapies for cancers driven by RAS signaling and PI3Kα. The company focuses on rational drug design to inhibit the active ON state of RAS and to selectively block RAS-driven PI3K activation, aiming at multiple KRAS mutants and novel approaches to maximize target inhibition. BBOT translates decades of RAS biology research into therapeutic candidates intended to improve outcomes for patients with RAS- and PI3Kα-driven tumors.
• Lead the clinical pharmacology strategy for multiple oncology programs, ensuring alignment with regulatory requirements and scientific standards. • Design and oversee clinical pharmacology studies to support multiple oncology program clinical development. • Collaborate with cross-functional teams, including clinical operations, biostatistics, and regulatory affairs, to drive the advancement of drug development programs. • Drive application of model-informed drug development (MIDD) approaches, including population PK/PD and exposure–response analyses. • Author relevant sections/modules of regulatory documents (including INDs, IBs, CTAs, IMPDs, NDAs, briefing packages, or other regulatory dossier) and serve as subject matter expert in regulatory interactions with FDA and other global health authorities. • Stay abreast of industry trends and advancements in clinical pharmacology and oncology, contributing to the scientific community through presentations and publications.
• Ph.D. or equivalent in pharmacokinetics (PK)/pharmacodynamics (PD), Pharmacology, Chemistry, or a related field. • Minimum of 10 years (SD) or 15 years (ED) of experience in clinical pharmacology, particularly with small molecule modality within the oncology therapeutic area. • Proven track record of successfully managing clinical pharmacology studies and developing regulatory submissions. • Strong understanding of oncology drug development processes and regulatory guidelines. • Quantitative pharmacology skillset preferred, e.g. PBPK, PK/PD modeling, population PK, and exposure-response analyses. • Excellent communication and interpersonal skills, with the ability to work collaboratively in a team environment.
• annual bonus • stock-based long-term incentives • medical • dental • vision benefits • retirement • wellness stipend • flexible time off
Apply Now🕒 March 27
Associate Director leading market development for biotechnology company focusing on regional commercial performance. Engaging KOLs and executing market strategies in collaboration with cross-functional teams.
🕒 March 27
Associate Director/ Director of Health Economics and Outcomes Research at Ionis Pharmaceuticals. Leading early evidence generation strategies and health economic modeling to support decision-making in clinical trials.
🕒 March 26
Senior Director of Analytics at Inizio Evoke driving performance measurement strategy across client engagements. Leading analytics teams and developing insights in healthcare marketing.
🕒 March 26
Senior Director of Analytics at Inizio Evoke responsible for leading performance marketing strategy and overseeing analytics for healthcare clients.
🕒 March 26
Senior Director leading performance marketing analytics strategy for healthcare at Inizio Evoke. Overseeing teams and delivering data-driven insights on client goals.